BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 11009565)

  • 1. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
    Takano H; Nagai T; Asakawa M; Toyozaki T; Oka T; Komuro I; Saito T; Masuda Y
    Circ Res; 2000 Sep; 87(7):596-602. PubMed ID: 11009565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
    Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
    Ye P; Fang H; Zhou X; He YL; Liu YX
    Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARalpha activators inhibit tissue factor expression and activity in human monocytes.
    Marx N; Mackman N; Schönbeck U; Yilmaz N; Hombach V; Libby P; Plutzky J
    Circulation; 2001 Jan; 103(2):213-9. PubMed ID: 11208679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
    Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
    Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion.
    Thuillier P; Anchiraico GJ; Nickel KP; Maldve RE; Gimenez-Conti I; Muga SJ; Liu KL; Fischer SM; Belury MA
    Mol Carcinog; 2000 Nov; 29(3):134-42. PubMed ID: 11108658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
    Simonin MA; Bordji K; Boyault S; Bianchi A; Gouze E; Bécuwe P; Dauça M; Netter P; Terlain B
    Am J Physiol Cell Physiol; 2002 Jan; 282(1):C125-33. PubMed ID: 11742805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.
    Uchimura K; Nakamuta M; Enjoji M; Irie T; Sugimoto R; Muta T; Iwamoto H; Nawata H
    Hepatology; 2001 Jan; 33(1):91-9. PubMed ID: 11124825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
    Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
    Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes.
    Teruel T; Clapham JC; Smith SA
    Biochem Biophys Res Commun; 1999 Oct; 264(2):311-5. PubMed ID: 10529360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR activators inhibit endothelial cell migration by targeting Akt.
    Goetze S; Eilers F; Bungenstock A; Kintscher U; Stawowy P; Blaschke F; Graf K; Law RE; Fleck E; Gräfe M
    Biochem Biophys Res Commun; 2002 May; 293(5):1431-7. PubMed ID: 12054675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
    Asakawa M; Takano H; Nagai T; Uozumi H; Hasegawa H; Kubota N; Saito T; Masuda Y; Kadowaki T; Komuro I
    Circulation; 2002 Mar; 105(10):1240-6. PubMed ID: 11889020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells.
    Nicholas SB; Kawano Y; Wakino S; Collins AR; Hsueh WA
    Hypertension; 2001 Feb; 37(2 Pt 2):722-7. PubMed ID: 11230363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.
    Chiba Y; Ogita T; Ando K; Fujita T
    Biochem Biophys Res Commun; 2001 Aug; 286(3):541-6. PubMed ID: 11511093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.
    Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM
    Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
    Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A
    Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.
    Sung CK; She H; Xiong S; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.